OLIG2 and glioblastoma: Targeting of these mutations to neural stem cells and oligodendrocyte-precursor cells (Syn-1) alone showed oncogenic potential, with intracranial tumors being observed and histological analysis showing a staining pattern consistent with GBM: positive for GFAP, Olig2, Sox2, PDGFR-alpha.